null Nadine Kronfli, MD, MPH, FRCP(C), DTM&H
HIV • hepatitis C • COVID-19 • vulnerable populations • people in prison • migrants • implementation science • evidence-based policies
My research focuses on designing, deploying, and evaluating evidence-based models of care that aim to increase engagement along the HIV and hepatitis C virus care cascades for vulnerable populations, with a particular focus on incarcerated and migrant populations. During the COVID-19 pandemic, my research has expanded to include seroprevalence studies in correctional facilities and interventions to increase COVID-19 vaccine uptake among people in prison. The ultimate goal of my research is to support the development of evidence-based policies to improve population health with an emphasis on eliminating certain infectious diseases such as hepatitis C and SARS-CoV-2 among neglected populations.
Duschene L, Dussault C, Godin A, et al. Implementing opt-out hepatitis C virus (HCV) screening in Canadian provincial prisons: a model-based cost-effectiveness analysis. Int J Drug Policy. 2021 Oct;96:103345.
Akiyama M, Kronfli N, Cabezas J, et al. Hepatitis C elimination among people incarcerated in prisons: challenges and recommendations for action within a health systems framework. Lancet Gastroenterol Hepatol. 2021 May;6(5):391-400.
Park H, Brenner B, Ibanescu RI, et al. Phylogenetic clustering among asylum seekers with new HIV diagnoses in Quebec, Canada. Viruses. 2021 Apr 1;13(4):601.
Kronfli N, Dussault C, Chalifoux S, et al. A randomized pilot study assessing the acceptability of rapid point-of-care hepatitis C virus (HCV) testing among male inmates in Montreal, Canada. Int J Drug Policy. 2020 Nov;85:102921.
Kronfli N, Young J, Wang S, et al. Liver fibrosis in HIV-HCV co-infection before and after sustained virologic response: what is the best non-invasive marker for monitoring regression? Clin Infect Dis. 2021 Aug 2;73(3):468-477.